|
Home
|
E-Submission
|
Sitemap
|
Editorial Office
|
Aims and Scope
About the Journal
Editorial Board
Open Access
Best Reviewer Awardees
Article Processing Charge
Editorial Office
Instructions for Authors
Research and Publication Ethics
Checklist
E-Submission
Copyright Transfer Agreement
All issues
Accepted Articles
Epub Ahead-of Print Articles
Current Issue
Most Read Articles
Most Cited Articles
Cancer Research and Treatment
Search
Author Index
Cancer Research and Treatment
Search
> Browse Articles > Search
Breast cancer
The Association of Estrogen Receptor Activity, Interferon Signaling, and MHC Class I Expression in Breast Cancer
In Hye Song, Young-Ae Kim, Sun-Hee Heo, Won Seon Bang, Hye Seon Park, Yeon ho Choi, Heejae Lee, Jeong-Han Seo, Youngjin Cho, Sung Wook Jung, Hee Jeong Kim, Sei Hyun Ahn, Hee Jin Lee, Gyungyub Gong
Cancer Res Treat.
2022;54(4):1111-1120. Published online December 21, 2021 DOI:
https://doi.org/10.4143/crt.2021.1017
Web of Science 1
Crossref 2
Axillary Lymph Node Dissection Does Not Improve Post-mastectomy Overall or Disease-Free Survival among Breast Cancer Patients with 1-3 Positive Nodes
Ji Hyeon Joo, Su Ssan Kim, Byung Ho Son, Seung Do Ahn, Jin Hong Jung, Eun Kyung Choi, Sei Hyun Ahn, Jong Won Lee, Hee Jeong Kim, Beom Seok Ko
Cancer Res Treat.
2019;51(3):1011-1021. Published online October 16, 2018 DOI:
https://doi.org/10.4143/crt.2018.438
Web of Science 15
Crossref 16
No Association of Positive Superficial and/or Deep Margins with Local Recurrence in Invasive Breast Cancer Treated with Breast-Conserving Surgery
Tae In Yoon, Jong Won Lee, Sae Byul Lee, Guiyun Sohn, Jisun Kim, Il Young Chung, Hee Jeong Kim, Beom Seok Ko, Byung Ho Son, Gyungyub Gong, Sung-Bae Kim, Su Ssan Kim, Seung Do Ahn, Minsung Chung, Sei Hyun Ahn
Cancer Res Treat.
2018;50(1):275-282. Published online April 14, 2017 DOI:
https://doi.org/10.4143/crt.2017.041
Web of Science 11
Crossref 12
Survival Outcome of Combined GnRH Agonist and Tamoxifen Is Comparable to That of Sequential Adriamycin and Cyclophosphamide Chemotherapy Plus Tamoxifen in Premenopausal Patients with Lymph-Node–Negative, Hormone-Responsive, HER2-Negative, T1-T2 Breast Cancer
Guiyun Sohn, Sei Hyun Ahn, Hee Jeong Kim, Byung-Ho Son, Jong Won Lee, Beom Seok Ko, Yura Lee, Sae Byul Lee, Seunghee Baek
Cancer Res Treat.
2016;48(4):1351-1362. Published online April 6, 2016 DOI:
https://doi.org/10.4143/crt.2015.444
Web of Science 7
Crossref 6
The Estimation of Breast Cancer Disease-Probability by Difference of Individual Susceptibility
Sue Kyung Park, Keun Young Yoo, Dae Hee Kang, Sei Hyun Ahn, Dong Young Noh, Kuk Jin Choe
Cancer Res Treat.
2003;35(1):35-51. Published online February 28, 2003 DOI:
https://doi.org/10.4143/crt.2003.35.1.35
Crossref 13
Retrospective Analysis of the Results of Adjuvant Chemotherapy in Breast Cancer Patients with 10 or More Positive Nodes: Nonrandomized Comparison of Adriamycin-Containing Regimens
Jin Hee Ahn, Haeseoung Bahng, Jeong Gyun Kim, Sung Bae Kim, Sei Hyun Ahn, Hyesook Chang, Jung Shin Lee, Sang Hee Kim, Woo Kun Kim
Cancer Res Treat.
2002;34(2):84-90. Published online April 30, 2002 DOI:
https://doi.org/10.4143/crt.2002.34.2.84
Crossref 1
The Reliability of Histoculture Drug Response Assay (HDRA) in Chemosensitivity Tests for Breast Cancer
Hee Joon Kang, Chang Dae Ko, Ho Sung Yoon, Moon Bo Kim, Sei Hyun Ahn
Cancer Res Treat.
2001;33(5):392-397. Published online October 31, 2001 DOI:
https://doi.org/10.4143/crt.2001.33.5.392
Crossref 4
1
Journal Impact Factor 4.6
> Browse Articles > Search
